BioSpace News Archive

Press Releases

Generation Lab raises $11 million, becoming Accel’s first longevity bet

October 23, 2025
·
1 min read
Press Releases

Trialogix Launches to Transform Clinical Trial Design with AI-Powered Optimization Platform

October 23, 2025
·
1 min read
Press Releases

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

October 23, 2025
·
17 min read
Press Releases

Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors

October 23, 2025
·
9 min read
Press Releases

CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

October 23, 2025
·
4 min read
Press Releases

HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity

October 23, 2025
·
5 min read
Press Releases

Coya Therapeutics Announces Proposed Public Offering of Common Stock - October 23, 2025

October 23, 2025
·
5 min read
Press Releases

Sydnexis Receives Complete Response Letter from FDA for SYD-101 to Slow Pediatric Myopia Progression

October 23, 2025
·
3 min read
Press Releases

Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2025 Financial Results

October 23, 2025
·
2 min read
Press Releases

CAGE Bio Announces Start of Double-Blind Vehicle-Controlled Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment

October 23, 2025
·
2 min read